Altogether, the T2DM models suggest that central obesity and dyslipidemia jointly contribute to reduced irisin levels, while the direct influence of insulin resistance markers diminishes when adiposity indices are considered. The gene discussed is FNDC5; the disease is Abdominal obesity.